Until recently, breast cancer was considered as a single disease with variable phenotype and expression of hormone receptors (HR; estrogen receptor, ER, and progesterone receptor, PR) and ERBB2 tyrosine kinase receptor. Here, ERBB2 is linked to breast carcinoma.